Altcoin News
  • Dow futures exploded higher on Monday, which saw massive gains across the global stock market.
  • The Trump administration is unloading every round of ammunition it has to make coronavirus treatments and vaccines available as quickly as possible.
  • A majority of economists believe there’s a significant risk the U.S. economy slides into a double-dip recession.

The Dow Jones bulls are in the driver’s seat on Monday, with futures pointing to a gigantic leap at the opening bell.

Stocks are trading up as the U.S. government goes all-in on bringing a coronavirus treatment to market.

Dow Futures Rocket Higher as Global Stocks Surge

As of 8:47 am ET, Dow futures had surged 265 points or 0.95% to 28,124. That implies a gain of just under 250 points at the opening bell.

dow jones futures todaydow jones futures today
Dow futures are priming the stock market for a massive opening bell gap. | Source: Yahoo Finance

S&P 500 and Nasdaq futures strolled toward similar gains, advancing 0.82% and 1.02%, respectively.

U.S. stock futures took their cues from global equity benchmarks, which rose across the board overnight as American traders slept.

In Asia, the Hang Seng Index closed 1.74% higher, while Korea’s KOSPI jumped 1.1%.

Some European indices rose even higher. The DAX shot up 2.38%, the FTSE 100 leaped 1.73%, and the STOXX 600 raced to a gain of 1.67%.

Trump Goes All-In to Fast-Track Coronavirus Treatments and Vaccines

Dow futures appear to be rallying on the Trump administration’s scramble to fast-track both a coronavirus treatment and a COVID-19 vaccine.

On Sunday, the Food and Drug Administration (FDA) authorized emergency use of convalescent plasma to treat hospitalized COVID-19 patients. This treatment – which has not been approved for general use – utilizes antibody-rich plasma from coronavirus survivors.

Here are former FDA chief Scott Gottlieb’s thoughts on the therapeutic treatment:

Almost simultaneously, the Financial Times reported that the Trump administration has mulled a plan to sidestep “normal… regulatory standards” to fast-track an experimental coronavirus vaccine candidate developed by AstraZeneca and Oxford University. AstraZeneca stock rose nearly 4% in pre-market trading today.

The twin developments unsurprisingly triggered a tidal wave of backlash from Trump’s political foes, who allege that the White House is more concerned about rushing coronavirus drugs to market before the election than ensuring they are both safe and effective.

donald trump attacks FDAdonald trump attacks FDA
Trump’s critics allege he is advocating for a reckless approach to coronavirus drug development to bolster his electoral prospects. He claims the “deep state” is deliberately slow-walking clinical testing. | Source: Twitter

Just one day earlier, Trump had scorched the FDA in a tweet, raving that the “deep state, or whoever, over at the FDA” was deliberately sabotaging the approval process, presumably to weaken the president’s reelection odds.

Economists Warn a ‘Double-Dip’ Recession Is Very Much on the Table

Although critics allege the Trump administration’s coronavirus strategy betrays misaligned priorities, there’s little debate about the stakes of producing an effective coronavirus vaccine.

A new survey from the National Association for Business Economics (NABE) found that economists view fighting COVID-19 as the White House’s most important policy consideration in 2021.

dow jones, u.s. economydow jones, u.s. economy
While the Dow continues to grind higher, almost half of economists believe U.S. GDP will remain below pre-pandemic levels until at least mid-2022. | Source: NABE

Addressing the pandemic ranks even higher than stimulating the economy. That’s particularly striking given how bearish their economic projections are.

Only 15% of respondents believe the recession ended in Q2 2020. Roughly half believe U.S. GDP won’t recover to pre-pandemic levels until at least 2022. And a full 80% believe the odds of a punishing double-dip recession are at least one-in-four.

Products You May Like

Articles You May Like

New Peer to Peer Exchange Provides Africans with an Alternative to Paxful
What Are The Top 5 Cryptocurrencies?
China’s Ant Group launches cross-border trade platform to support SMEs
Uniswap’s UNI Token May Reel to $3.30 as Selling Pressure Ramps Up
Crypto Leverage Trading: How To Not Get Liquidated – Bitcoin Trading Strategy
The Key to DeFi Entering a New Level Is CeFi

Leave a Reply

Your email address will not be published. Required fields are marked *